144P Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer (TD-NICE): A single arm, phase II study
Title:
144P Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer (TD-NICE): A single arm, phase II study
Author:
Yan, X. Zhao, J. Lei, J. Duan, H. Ni, Y. Zhou, Y. Wang, X. Qi, H. Liu, H. Tian, F. Lu, Q. Sun, J. Yang, E. Zhong, D. Wang, T. Huang, L. Wang, J. Jiang, T.